Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.

about

Silencing of fanconi anemia complementation group f exhibits potent chemosensitization of mitomycin C activity in breast cancer cells.

P2860

Q37240042-1ECAC749-5AFA-46C3-8A2E-5BD90AF8D09B

P2860

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.

Item

http://www.wikidata.org/entity/Q36616994

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Mitomycin C, vinblastine and c ...... en for advanced breast cancer.

@ast

Mitomycin C, vinblastine and c ...... en for advanced breast cancer.

@en

type

Item

label

Mitomycin C, vinblastine and c ...... en for advanced breast cancer.

@ast

Mitomycin C, vinblastine and c ...... en for advanced breast cancer.

@en

prefLabel

Mitomycin C, vinblastine and c ...... en for advanced breast cancer.

@ast

Mitomycin C, vinblastine and c ...... en for advanced breast cancer.

@en

P1476

Mitomycin C, vinblastine and c ...... en for advanced breast cancer.

@en

P2093

A Urruticoechea

http://www.w3.org/2001/XMLSchema#string

C D Archer

http://www.w3.org/2001/XMLSchema#string

G Walsh

http://www.w3.org/2001/XMLSchema#string

I E Smith

http://www.w3.org/2001/XMLSchema#string

L A Assersohn

http://www.w3.org/2001/XMLSchema#string

M Verrill

http://www.w3.org/2001/XMLSchema#string

R K Gregory

http://www.w3.org/2001/XMLSchema#string

R Mendes

http://www.w3.org/2001/XMLSchema#string

S R D Johnston

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.

A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.

Carboplatin activity in untreated metastatic breast cancer patients--results of a phase II study.

Carboplatin in combination as first-line therapy in advanced breast cancer.

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study.

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

P2888

sj.bjc.6602367

P304

475-479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602367

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8047610

http://www.w3.org/2001/XMLSchema#string

P6179

1003273915

http://www.w3.org/2001/XMLSchema#string

P698

15685237

http://www.w3.org/2001/XMLSchema#string

P932

2362079

http://www.w3.org/2001/XMLSchema#string

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.

about

P2860

P2860

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P932